Detailansicht

Wissensnetz

Person

Rolf W. Hartmann (1952-)

Chemiker

Name	Rolf W. Hartmann
Zeit	1952- (Lebensdaten)
Ort	Saarbrücken (Wirkungsort) Deutschland
Beruf	Chemiker (charakteristischer Beruf)
Variante	Rolf Hartmann
Beziehung	Helmholtz-Institut für Pharmazeutische Forschung Saarland Universität des Saarlandes
Datensatztyp	Person
GND-Nummer	1167342445
Datensatz-ID	1167342445
Beteiligt an alle anzeigen Application of the crystalline sponge method for metabolite structure elucidation Entwicklung von 17β-HSD2-Inhibitoren mit und ohne Strukturelement für das Knochen-Targeting Metabolic Profiling of S-praziquantel : Structure Elucidation Using the Crystalline Sponge Method in Combination with Mass Spectrometry and Nuclear Magnetic Resonance Phosphonate as a Stable Zinc-Binding Group for "Pathoblocker" Inhibitors of Clostridial Collagenase H (ColH) Substrate-Inspired Fragment Merging and Growing Affords Efficacious LasB Inhibitors Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols Development of novel drug-like molecules for targeted therapy Development of Pathoblockers by Targeting Secreted Bacterial Proteases Lead optimization of highly potent and selective CYP11B1 inhibitors for the treatment of Cushing’s syndrome and chronic wounds From Small Organic Molecules to Peptides As Tools For Anti-infectives Drug Discovery In-depth Profiling of MvfR-Regulated Small Molecules in Pseudomonas aeruginosa after Quorum Sensing Inhibitor Treatment Recent Progress in Pharmaceutical Therapies for Castration-Resistant Prostate Cancer Synthesis and Biological Evaluation of Thieno[3,2-d]- pyrimidinones, Thieno[3,2-d]pyrimidines and Quinazolinones : Conformationally Restricted 17b-Hydroxysteroid Dehydrogenase Type 2 (17b-HSD2) Inhibitors

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Rolf W. Hartmann (1952-)

Application of the crystalline sponge method for metabolite structure elucidation

Entwicklung von 17β-HSD2-Inhibitoren mit und ohne Strukturelement für das Knochen-Targeting

Metabolic Profiling of S-praziquantel : Structure Elucidation Using the Crystalline Sponge Method in Combination with Mass Spectrometry and Nuclear Magnetic Resonance

Phosphonate as a Stable Zinc-Binding Group for "Pathoblocker" Inhibitors of Clostridial Collagenase H (ColH)

Substrate-Inspired Fragment Merging and Growing Affords Efficacious LasB Inhibitors

Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols

Development of novel drug-like molecules for targeted therapy

Development of Pathoblockers by Targeting Secreted Bacterial Proteases

Lead optimization of highly potent and selective CYP11B1 inhibitors for the treatment of Cushing’s syndrome and chronic wounds

From Small Organic Molecules to Peptides As Tools For Anti-infectives Drug Discovery

In-depth Profiling of MvfR-Regulated Small Molecules in Pseudomonas aeruginosa after Quorum Sensing Inhibitor Treatment

Recent Progress in Pharmaceutical Therapies for Castration-Resistant Prostate Cancer

Synthesis and Biological Evaluation of Thieno[3,2-d]- pyrimidinones, Thieno[3,2-d]pyrimidines and Quinazolinones : Conformationally Restricted 17b-Hydroxysteroid Dehydrogenase Type 2 (17b-HSD2) Inhibitors